ARCHIVES

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

This article is from The Cancer Letter archive.

Vol. 08 No. 39 | October 8, 1982

Download PDF Visit The Full Archive

Related Articles

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

NCI program announcement available, contract awards listed.

November 14, 2003

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001